The abstract is read at the publisher; the summary is JClub's.
In a multinational prospective cohort of hospitalized alcohol-associated hepatitis patients, metabolic dysfunction and cardiometabolic risk factors were not linked to higher 180-day mortality, while age, alcohol intake, MELD, and ACLF grade predicted death.
- Why it matters: The prognostic role of cardiometabolic risk factors in alcohol-associated hepatitis is unclear, despite their established relevance in steatotic liver disease.
- What they did: From 2015–2024 across 32 centers in 14 countries, 936 patients diagnosed by National Institute on Alcohol Abuse and Alcoholism criteria were followed for 180-day outcomes using adjusted competing-risk models with liver transplantation as a competing event.
- The result: Survival did not differ by cardiometabolic risk factor status (log-rank p=0.453), and no single cardiometabolic risk factor independently increased mortality; higher age (sHR 1.03), alcohol intake (per g/day sHR 1.001), MELD (sHR 1.04), and ACLF grade 2–3 (sHR 2.34 and 4.34) predicted mortality, with BMI showing modestly lower mortality between 25 and 40 kg/m² and higher risk above 40 kg/m².
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.